Basile-Borgia A, Abel J H, Mahloogi H
Department of Cardiovascular Perfusion, Easton Hospital, Pennsylvania 18042, USA.
Perfusion. 1999 Mar;14(2):89-99. doi: 10.1177/026765919901400202.
Recent advances in the field of molecular biology have led to a better understanding of the pathological mechanisms of cardiovascular disease. The impact of these findings will shape the future of treatment modalities for cardiovascular disorders. Postulated targets and biological rationale of new techniques are being developed in a race towards molecular therapies for vascular diseases. Whether it is modulation of transmembrane cell receptors or phenotypic changes via vectors that mediate gene transfer, there is no doubt that molecular strategies will be an integral part of the future. Here we examine past and recent perspectives, describe directions and challenges in cardiac and cardiovascular areas of research, and discuss relevance to the field of cardiovascular perfusion.
分子生物学领域的最新进展使人们对心血管疾病的病理机制有了更深入的了解。这些研究结果的影响将塑造心血管疾病治疗方式的未来。在竞相开发针对血管疾病的分子疗法的过程中,新技术的假定靶点和生物学原理正在不断发展。无论是跨膜细胞受体的调节还是通过介导基因转移的载体实现的表型变化,毫无疑问,分子策略将成为未来不可或缺的一部分。在此,我们审视过去和近期的观点,描述心脏和心血管研究领域的方向与挑战,并讨论其与心血管灌注领域的相关性。